Skip to content
OpenCapital
Get started

ORIQ ORIQ Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
Microbot Medical logo
Microbot MedicalMBOT
16.3M—
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M—
Unusual Machines logo
Unusual MachinesUMAC
0-100%
The Marygold Companies logo
The Marygold CompaniesMGLD
82.5K—
KRAKacquisition logo
KRAKacquisition KRAQ
0—

Other financials

Income statement

See full
Net income$390.6K+8,603%
EPS (diluted)$0.04—

Balance sheet

See full
Cash & equivalents$834.1K—
Total equity$844.3K+6,827%
Total assets$72.6M—

Cash flow

See full
Operating cash flow-$317.7K—

Valuation

See full
Market cap$88.92M+3.1%
P/E82.5×—

Returns & leverage

See full
Return on equity251.8%—
Current ratio8.8×—

Where this comes from

Reported directly by ORIQ in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: ORIQ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about ORIQ's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ORIQ's warrants and rights outstanding?
ORIQ (ORIQ) reported warrants and rights outstanding of 3.9M in Q1 2026.
What does warrants and rights outstanding mean?
This metric quantifies the total number or value of derivative instruments that grant holders the right to purchase company shares at a specified price within a defined timeframe. It is a critical indicator of potential future equity dilution for existing shareholders. Investors track this to understand the impact of potential share issuance on earnings per share and overall ownership structure.